Cruz P D, East C, Bergstresser P R
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas 75235.
J Am Acad Dermatol. 1988 Jul;19(1 Pt 1):95-111. doi: 10.1016/s0190-9622(88)70157-7.
Many patients with lipoprotein disorders are at increased risk for the development of premature atherosclerosis and, less commonly, other disorders that cause systemic morbidity. In some of these patients, xanthomas also develop and provide cutaneous markers for the lipoprotein disorder. As advances in molecular biology refine our understanding of lipoprotein metabolism, it has become increasingly clear that several types of xanthomas are associated with specific disease states. This article presents a differential diagnosis of xanthomas that incorporates contemporary thinking about lipoprotein disorders and focuses on the relationship between abnormalities in lipoprotein metabolism, content, or structure and the development of specific xanthomas.
许多脂蛋白紊乱患者发生早发性动脉粥样硬化的风险增加,较少见的是发生导致全身发病的其他疾病。在其中一些患者中,还会出现黄色瘤,为脂蛋白紊乱提供皮肤标志物。随着分子生物学的进展使我们对脂蛋白代谢的理解更加精确,越来越清楚的是,几种类型的黄色瘤与特定的疾病状态相关。本文提出了一种黄色瘤的鉴别诊断方法,该方法纳入了对脂蛋白紊乱的当代认识,并着重于脂蛋白代谢、含量或结构异常与特定黄色瘤发生之间的关系。